Showing results (11-20 of 162) with videos related to
Sort By:
Pageof 17
Neurosurgery|May 23, 2008
Initial experience with bioactive cerecyte detachable coils: impact on reducing recurrence ratesErol Veznedaroglu, Christopher J Koebbe, Adnan Siddiqui, et al.Journal of Proteome Research|July 30, 2024
Unveiling Pathophysiological Insights: Serum Metabolic Dysregulation in Acute Respiratory Distress Syndrome Patients with Acute Kidney InjuryAnamika Singh, Mohd Adnan Siddiqui, Swarnima Pandey, et al.IEEE Transactions on Bio-Medical Engineering|July 12, 2018
Design and Development of Surgeon Augmented Endovascular Robotic SystemNaveen Kumar Sankaran, Pramod Chembrammel, Adnan Siddiqui, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|June 14, 2006
Clinical study of Fuchs corneal endothelial dystrophy leading to penetrating keratoplasty: a 30-year experienceNatalie A Afshari, Aaron B Pittard, Adnan Siddiqui, et al.Journal of Inflammation Research|June 28, 2014
Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cellsSushovita Mukherjee, Mohammad Adnan Siddiqui, Shubham Dayal, et al.Molecular Omics|December 9, 2021
Gender-specific association of oxidative stress and immune response in septic shock mortality using NMR-based metabolomicsSwarnima Pandey, Mohd Adnan Siddiqui, Surendra Kumar Trigun, et al.Journal of Neurointerventional Surgery|April 15, 2016
Flow diversion with Pipeline Embolic Device as treatment of subarachnoid hemorrhage secondary to blister aneurysms: dual-center experience and review of the literatureItalo Linfante, Michael Mayich, Ashish Sonig, et al.Biophysical Chemistry|September 10, 2020
Metabolomics: An emerging potential approach to decipher critical illnessesMohd Adnan Siddiqui, Swarnima Pandey, Afzal Azim, et al.Molecular Omics|January 5, 2021
Serum metabolic profiles of septic shock patients based upon co-morbidities and other underlying conditionsSwarnima Pandey, Mohd Adnan Siddiqui, Afzal Azim, et al.Nature Communications|March 7, 2026
Recurrent and novel evolutionary pathways drive in vitro HIV-1 lenacapavir resistance with diverse phenotypic consequencesLuke L Orris, Mohammad Adnan Siddiqui, Junyi Tang, et al.Pageof 17